Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas - PubMed (original) (raw)
Affiliations
- PMID: 15377470
Meta-Analysis
Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas
Giorgio Malpeli et al. Haematologica. 2004 Sep.
Abstract
Background and objectives: Somatic hypermutation of the BCL6 gene and its expression in lymphoma represent specific markers for B-cell transit through the germinal center. Thus, analysis of BCL6 may aid in clarifying the relationship between primary mediastinal B-cell lymphoma (PMBL) and other non-thymic diffuse large cell lymphomas (DLCL).
Design and methods: Twenty-four PMBL were analyzed for BCL6 status, including first intron mutations, by quantitative reverse transcription polymerase chain reaction (RT-PCR), and immunohistochemistry. We also performed a meta-analysis of reported BCL6 mutations in PMBL (n=141), DLCL (n=233), and follicular lymphoma (n=120).
Results: Thirteen PMBL (54%) showed hypermutation of BCL6. All cases showed bcl6 mRNA and immunohistochemical expression. Meta-analysis demonstrated that the preferentially altered sequence motifs of BCL6 in PMBL were TA (p=0.002) and AT (p=0.0008) dinucleotides and TAT trinucleotides (p=0.001). GC and RGYW/WRCY motifs were a target in DLCL and FL but not in PMBL. Moreover, the DNA stretch spanning nucleotides 150-270 was highly targeted only in PMBL.
Interpretation and conclusions: The consistent expression of bcl6 protein and occurrence of hypermutation indicate that PMBL should be considered of germinal center origin. The fact that the hypermutation sites and mutational spectrum of BCL6 in PMBL differ from those found in FL and DLCL might suggest that the maturation block of the transforming cells differs among these tumor types, and that the characteristic mutational pattern is present before neoplastic transformation. Thus, our findings strengthen the hypothesis that PMBL originate from an already defined sub-population of B-cells, which are different from those leading to either DLCL or FL.
Similar articles
- Nonimmunoglobulin gene hypermutation in germinal center B cells.
Peng HZ, Du MQ, Koulis A, Aiello A, Dogan A, Pan LX, Isaacson PG. Peng HZ, et al. Blood. 1999 Apr 1;93(7):2167-72. Blood. 1999. PMID: 10090923 - Molecular characterization of primary mediastinal B cell lymphoma.
Tsang P, Cesarman E, Chadburn A, Liu YF, Knowles DM. Tsang P, et al. Am J Pathol. 1996 Jun;148(6):2017-25. Am J Pathol. 1996. PMID: 8669486 Free PMC article. - Somatic mutation of the 5' noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma.
Szereday Z, Csernus B, Nagy M, László T, Warnke RA, Matolcsy A. Szereday Z, et al. Am J Pathol. 2000 Mar;156(3):1017-24. doi: 10.1016/S0002-9440(10)64969-3. Am J Pathol. 2000. PMID: 10702417 Free PMC article. - The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis.
Jardin F, Ruminy P, Bastard C, Tilly H. Jardin F, et al. Pathol Biol (Paris). 2007 Feb;55(1):73-83. doi: 10.1016/j.patbio.2006.04.001. Epub 2006 Jul 3. Pathol Biol (Paris). 2007. PMID: 16815642 Review. - Pathobiology of primary mediastinal B-cell lymphoma.
Pileri SA, Zinzani PL, Gaidano G, Falini B, Gaulard P, Zucca E, Sabattini E, Ascani S, Rossi M, Cavalli F; International Extranodal Lymphoma Study Group. Pileri SA, et al. Leuk Lymphoma. 2003;44 Suppl 3:S21-6. doi: 10.1080/10428190310001623810. Leuk Lymphoma. 2003. PMID: 15202521 Review.
Cited by
- Knock-down of BCL6 / STAT6 sensitizes primary B cell lymphoma cells for treatment with current therapeutic agents.
Häberle MT, Kelsch E, Dorsch K, Möller P, Ritz O. Häberle MT, et al. Oncoscience. 2014 Apr 30;1(4):283-6. doi: 10.18632/oncoscience.35. eCollection 2014. Oncoscience. 2014. PMID: 25594020 Free PMC article. - Primary mediastinal large B-cell lymphoma.
Dabrowska-Iwanicka A, Walewski JA. Dabrowska-Iwanicka A, et al. Curr Hematol Malig Rep. 2014 Sep;9(3):273-83. doi: 10.1007/s11899-014-0219-0. Curr Hematol Malig Rep. 2014. PMID: 24952250 Free PMC article. - STAT6-mediated BCL6 repression in primary mediastinal B-cell lymphoma (PMBL).
Ritz O, Rommel K, Dorsch K, Kelsch E, Melzner J, Buck M, Leroy K, Papadopoulou V, Wagner S, Marienfeld R, Brüderlein S, Lennerz JK, Möller P. Ritz O, et al. Oncotarget. 2013 Jul;4(7):1093-102. doi: 10.18632/oncotarget.1149. Oncotarget. 2013. PMID: 23852366 Free PMC article. - Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma.
Ritz O, Guiter C, Castellano F, Dorsch K, Melzner J, Jais JP, Dubois G, Gaulard P, Möller P, Leroy K. Ritz O, et al. Blood. 2009 Aug 6;114(6):1236-42. doi: 10.1182/blood-2009-03-209759. Epub 2009 May 7. Blood. 2009. PMID: 19423726 Free PMC article. - Identification of murine B cell lines that undergo somatic hypermutation focused to A:T and G:C residues.
Bhattacharya P, Grigera F, Rogozin IB, McCarty T, Morse HC 3rd, Kenter AL. Bhattacharya P, et al. Eur J Immunol. 2008 Jan;38(1):227-39. doi: 10.1002/eji.200737664. Eur J Immunol. 2008. PMID: 18081040 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous